Dose-Response: An International Journal
Volume 8 | Issue 1

Article 7

3-2010

HORMESIS IS APPLICABLE AS A PROHEALTHY AGING INTERVENTION IN
MAMMALS AND HUMAN BEINGS
Marie-Christine Pardon
University of Nottingham Medical School

Follow this and additional works at: https://scholarworks.umass.edu/dose_response
Recommended Citation
Pardon, Marie-Christine (2010) "HORMESIS IS APPLICABLE AS A PRO-HEALTHY AGING INTERVENTION IN MAMMALS
AND HUMAN BEINGS," Dose-Response: An International Journal: Vol. 8 : Iss. 1 , Article 7.
Available at: https://scholarworks.umass.edu/dose_response/vol8/iss1/7

This Article is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in Dose-Response: An
International Journal by an authorized editor of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.

Pardon: Hormesis as a pro-healthy aging intervention

Dose-Response, 8:22–27, 2010
Formerly Nonlinearity in Biology, Toxicology, and Medicine
Copyright © 2010 University of Massachusetts
ISSN: 1559-3258
DOI: 10.2203/dose-response.09-020.Pardon

HORMESIS IS APPLICABLE AS A PRO-HEALTHY AGING INTERVENTION IN
MAMMALS AND HUMAN BEINGS

Marie-Christine Pardon

䊐

University of Nottingham Medical School

䊐 The aging of the population brings new heath challenges, and in particular, the need
to implement suitable pro-healthy aging interventions. This paper discusses the potential
of mild stressors inducing hormesis as a lifespan and healthspan extension strategy and
how it can be applied to the human. There is some evidence that the anti-aging benefits
of lifestyle factors, such as diet, exercise or engaging in activities may be achieved via
hormetic regulation. This supports the validity of the concept in human. There are, however, gaps in knowledge and ethical barriers that need to be addressed to establish the suitability of the approach to the clinical context or the general geriatric population. In particular, we need to find out which stressors are safe for use as anti-aging interventions,
when they have to be applied to achieve maximal benefits, how their therapeutic potential is altered by changes in the stress system induced by age and pathological conditions,
and the extent to which the occurrence of adverse versus positive effects depends on interacting genetic and experiential factors.
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INTRODUCTION

The substantial increase in the mean lifespan since the 19th century is
a recent phenomenon constituting an unprecedented economic challenge for modern societies (Louria 2005; Olshansky et al. 2007). About
15% of the population of developed countries is aged over 65; this proportion is expected to reach 20% by 2030 (12% worldwide) leading to an
increased incidence of long lasting pathological states (Kinsella and
Velkoff 2001), amongst which devastating dementias such as Alzheimer’s
disease (AD). Thus, healthy aging is a key priority. The concept of hormesis has the potential to increase our understanding of the mechanisms
mediating successful aging and our ability to develop suitable interventions to achieve this.
In biological gerontology, hormesis applies to the beneficial actions
resulting from a mild activation of the stress system triggering positive,
adaptive effects; beneficial outcomes include enhanced coping with
and ability to resist a more severe stress that might other wise cause
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dysfunction or disease, increased longevity, retardation of senescent deterioration and age-related disease (Masoro 2000; Mattson 2008b; Rattan
2008). To date most of our knowledge on hormetic regulation of the
aging process comes from invertebrate studies and human cells in culture. The suitability of the approach in promoting healthy aging in
human is yet to be established. The gaps in knowledge, challenges and
barriers to the implementation of hormesis as a pro-healthy aging intervention in human will be discussed here.
MILD-STRESS-INDUCING HORMESIS CAN INCREASE HEALTHSPAN

From a biological point of view, this concept makes sense and is supported by some evidence in experimental animals, but the main barrier
is ethical. The general view is that stress is a harmful state, and therefore,
the concept can be seen as unacceptable unless there is a clear understanding of the dose-response relationship; a concept that may be difficult to grasp at the level of the society.
Our body responds to stress by setting into motion a number of mechanisms designed to protect it from adverse health effects, e.g. enhanced
immune function, neuroprotection and cognitive function. Thus, it is
conceivable, and it has been pioneerly proven in rats by Frolkis (1982),
that the exposure to mild stressors can strengthen the organism’s defense
mechanisms and result in a longer and healthier life. It is only when this
response is excessive, either in intensity or in duration that adverse health
effects occur. A good illustration of the validity of the concept comes from
our recent work showing that the repeated exposure to a novel environment, which induces a mild stress response, is able to delay the progression of cognitive and neuropathological changes relevant to AD in a
genetic mouse model (Pardon et al. 2009; Rattray et al. 2009), despite this
condition being incurable. By contrast, others have found an accelerated
disease progression in mouse models of AD when exposed to more severe
chronic stressors, such as social isolation or repeated 6-h immobilization
sessions (Dong et al. 2004; Jeong et al. 2006).
MILD STRESSORS-INDUCING HORMESIS SAFE FOR USE IN MAMMALS
AND HUMANS.

A number of situations qualify as potential paradigms for hormesis.
Which one to use depends on several factors to include the species and
long-term objectives. In rodents and other experimental animals, the
intensity of the stressor can be controlled in many ways (e.g. duration, frequency, intermittence), such that it is technically feasible to test if low
doses of established adverse events would trigger positive effects, as a
proof of concept. It is nevertheless thought that not all mild stressors will
induce hormesis, and many examples have been reported where low
intensity stimulations can produce adverse effects (Calabrese et al. 2006).
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It is therefore essential to screen in animals which interventions are able
to induce hormesis in order to understand better the underlying mechanisms, regardless of their applicability to the human situation. However,
when the ultimate aim is to translate animal research into clinical use, the
range of potential mild stressors is limited by ethical issues. Whilst it is
possible that the short-term (minutes) exposure to physical stressors such
as cold, aggressive interactions or immobilization, will induce hormesis in
animals, the use of similar situations in humans to promote health is
unthinkable. Thus, the above question has to be addressed from an outcome perspective, i.e. are any of the established or suspected pro-healthy
aging interventions paradigms for hormesis? To date, the strongest candidates for use in human are moderate exercise (Gomez-Pinilla 2008;
Goto et al. 2007), calorie restriction (Mattson 2008a) and possibly novelty (engaging in novel social and organizational activities in human)
(Pardon et al. 2009) or cognitive challenges (Rattan 2008).
CAN HORMESIS BE INDUCED IN SUBJECTS VULNERABLE TO STRESS?

Hormesis is a very likely mechanism underlying the benefits of a
healthy, active lifestyle. Thus, it could be considered as an accepted mean
of achieving increased healthspan. Indeed, modern societies and a number of aging-related charities are raising awareness of the health benefits
of healthy eating, exercise and engaging in activities. Although the mechanisms mediating hormetic regulation are far from being fully established, the observed beneficial outcome constitutes a sufficient proof of
concept to support the application to human health.
Two key inter-related questions, however, need to be addressed prior
to the systematic use of lifestyle factors inducing hormesis in a clinical
context or its application to the general geriatric population.
1. Will all individuals similarly experience positive effects of mild stressors, or will the outcomes result from interacting genetic and experiential factors?
2. How and when mild stressors need to be applied to be effective
and/or result in maximal healthspan benefits?
Inter-individual variability in the ability to cope with stress, due to age
or other personal factors, is there a key issue. As discussed before (Pardon
2007), one may expect that because of a deficient stress system, the low
resistance of subjects vulnerable to stress would be such that lower levels
of stress will trigger negative effects and accelerate age-related pathologies. However, our recent work suggests that this is not the case, and even
that, in some circumstances, a hormetic response is more likely to occur
in individuals susceptible to stress. Indeed, genetic mouse models of AD
show sign of vulnerability to stress prior to onset of pathological markers
24
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(Pardon 2007), but we found that the repeated exposure to mild novelty
stress improved cognitive and pathological markers in such mice (Pardon
et al. 2009; Rattray et al. 2009) whilst impairing memory performance in
the stress-resistant C57b/l6 mouse line (Scullion et al. 2009). Moreover,
the ability to cope with stress generally declines with age, but recent evidence also suggest that age is not a key issue to the occurrence of hormetic effects of exercise in normal rats (Goto et al. 2007). Thus, the conditions in which hormesis will work is an intriguing question that needs to
be elucidated before considering it as a suitable anti-aging strategy. This
is complicated by the fact that some mild stressors may induce hormesis
in a sub-population while producing adverse effects in others.
HORMESIS MAY HELP PREVENTING OR DELAYING NEURODEGENERATIVE DISEASES.

The mild stressors effective in extending lifespan and healthspan,
such as enrichment or exercise in rodents, have also been shown to delay
the progression of pathological markers in mouse models of neurodegenerative conditions such as AD (Pardon 2007) or Parkinson’s disease
(Pothakos et al. 2009). And in human, a very recent study emphasized
that people who engage more in physical, social, leisure or organizational activities have a reduced risk of developing AD (Wang et al. 2009).
As far as dementia is concerned, pre-clinical evidence to date points
towards a higher preventive than therapeutic potential of mild stress
exposure. For instance, in AD mice, voluntary exercise was found to
attenuate the age-related accumulation of senile plaques (mainly composed of amyloid beta peptide 42 (Abeta1-42)) when applied from prior
to the onset of the amyloid pathology (Adlard et al. 2005). The same
intervention reduced the Abeta1-42/Abeta1-40 ratio without any effect
on amyloid plaque load in aged mice showing severe amyloid pathology
(Mirochnic et al. 2009) despite still having some cognition-enhancing
effects (Parachikova et al. 2008). The nature of the stressor may also play
a role, as we found that the repeated exposure to novelty prevented the
development of a memory and re-learning deficit in AD mice, but did not
reverse those once established (Pardon et al. 2009; Rattray et al. 2009).
This indicates that the benefits of mild stressors may decrease as the disease progresses, with still some potential for improved health.
THE APPLICATION OF HORMESIS TO HUMANS FOR HEALTHSPAN
IMPROVEMENT IS LIMITED BY GAPS IN KNOWLEDGE.

As mentioned before, we really need to know which ethically acceptable mild stressors can provide hormetic regulation of age-related disease
processes. The fact that candidate stressors emerges as being part of an
active lifestyle will facilitate the implementation of the approach to the
human. In addition, since hormesis act through inducing a mild stress
25
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response, it is essential to understand the consequences that may arise
when applied to an impaired stress system. It is thus critical to expand our
knowledge on how the stress system age or is altered by related-medical
conditions and to establish whether mild stressors can do more benefits
than harm under such circumstances.
In summary, mild stressors inducing hormesis have the potential to
expand lifespan and healthspan in human and even to improve incurable
age-related brain diseases. The application of hormesis to the human will
be facilitated by the fact that the strongest candidates are part of an
active, healthy lifestyle, and are perceived as positive environmental factors. There is, however, a need to increase our knowledge on how the
therapeutic potential is altered by advancing age or pathological status,
prior to accepting hormesis as a suitable pro-healthy aging intervention.
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